Adiposs SA is developing ImageBAT™, a first-in-class CT contrast agent designed to non-invasively identify patients with increased risks of cancer progression and treatment failure. This technology enhances diagnostic imaging by providing critical insights into brown fat metabolism, which is linked to patient survival outcomes.

Almer develops lightweight augmented reality (AR) devices that provide hands-free communication and real-time guidance for frontline workers in challenging environments. Their technology enhances operational efficiency by connecting field technicians with remote experts, enabling instant support and knowledge transfer without the need for physical presence.

This startup offers a digital health plan focused on preventative care, providing users with a dedicated healthcare team for personalized and comprehensive support. The service aims to deliver proactive and predictive healthcare solutions tailored to individual needs.

ASTRA Therapeutics develops targeted therapeutics using advanced biopharmaceutical techniques to address unmet medical needs in disease treatment. The company focuses on leveraging proprietary drug delivery systems to enhance the efficacy and safety of medications for patients with complex health conditions.

BTRY provides ultra‑thin (0.1 mm) flexible solid‑state batteries that can be fully charged and discharged in one minute, operate reliably up to 150 °C, and deliver high‑power bursts without flammable liquids. The roll‑to‑roll foil format integrates directly into device substrates, enabling compact, fast‑charging power sources for IoT sensors, medical wearables, and consumer electronics while offering scalable, cost‑effective manufacturing.

CellX Biosolutions develops bacterial-based biotechnologies to degrade persistent chemical pollutants such as PFAS, pharmaceutical residues, agro‑chemical waste, and microplastics. Their platform isolates and optimizes native bacterial communities, then scales them into commercial treatment solutions for wastewater and contaminated sites. This approach offers a sustainable, cost‑effective alternative to conventional chemical waste disposal methods.

Cowa Thermal Solutions develops thermal energy storage systems utilizing phase-change materials to enhance the efficiency and compactness of heating systems. Their technology enables significant energy cost savings and reduces carbon emissions by storing excess energy from heat pumps and photovoltaic systems.

CustomSurg provides an FDA‑cleared AI algorithm, OrthoPlanner™, that automatically generates pre‑operative fracture plans from imaging scans. The platform delivers detailed surgical insights quickly, helping orthopedic trauma surgeons improve accuracy and efficiency. By integrating deep‑tech research from Harvard and ETH Zurich, it supports evidence‑based decision‑making in fracture surgery.

DAAV develops AI-enabled robotic wheelchairs designed for autonomous navigation within airports. This system enhances mobility for passengers with reduced mobility by providing automated crowd navigation and obstacle avoidance. The technology aims to improve passenger experience while reducing operational workload for PRM service providers.

Flowbone develops an injectable bioactive hydrogel that promotes in‑situ bone mineralization to strengthen hip regions at high risk of fracture. The platform integrates with native bone biology, preserving vascularization and biomechanics without leaving foreign material. By delivering the gel minimally invasively via cannula, it aims to reduce osteoporotic hip fractures and associated healthcare costs.

Galventa develops patented galenic formulations that enhance the bioavailability and release profiles of nutraceutical and OTC products. Its delivery systems are validated through human clinical trials to ensure safety and efficacy. The company offers these technologies for licensing or distribution to improve product performance in the health supplement market.

JumboSync provides developers with a no-code interface and APIs to implement passwordless authentication, user management, and secure identity validation in their applications. This solution addresses the challenges of session theft and credential stuffing, enabling a seamless and secure user experience.

KIDEMIS develops sustainable mycoprotein ingredients derived from upcycled agricultural sidestreams to serve as a high-quality alternative to fishmeal and fish oil in aquafeed. This biotechnology solution reduces pressure on wild fish stocks and lowers the environmental impact associated with traditional aquaculture feed production. The resulting ingredients offer a cost-effective and scalable protein source to support global food security through responsible aquaculture.

Luya produces plant-based food products using whole organic legumes and traditional fermentation methods, avoiding imitation meat and ultra-processed ingredients. Their offerings, such as the Super Crispy Luya Nuggets and Simply Natural Luya Geschnetzeltes, provide a nutritious, high-protein alternative that addresses the demand for healthier, sustainable food options.

Mindler provides an AI‑enhanced career guidance platform that uses a five‑dimensional assessment to generate personalized career, stream, and college recommendations. The service includes one‑on‑one counseling with certified coaches, end‑to‑end college application support (including scholarships and internships), and a digital library of career resources, while offering schools a white‑label dashboard to manage and scale counseling workflows.

Neurosoft Bio creates ultra‑soft, elastic brain‑computer interface devices that match neural tissue mechanics, allowing minimally invasive implantation through tiny burr holes and reducing scar tissue, hematoma, and brain compression. Their platform combines foldable, ultra‑thin electrode arrays with AI‑driven signal processing to extract biomarkers, optimize neuromodulation, and decode motor or speech intentions for diagnostic and therapeutic use in neurological disorders.

NXI Therapeutics is developing selective immunosuppressive drugs that target the coronin 1 protein to modulate T cell responses, thereby minimizing the risk of infections and tumors associated with conventional immunosuppressants. This approach aims to enhance the efficacy and safety of treatments for autoimmune diseases and organ transplantation without compromising the immune system's protective functions.

Adularia develops tumor‑targeted immunotherapies that harness microbiome‑derived immune regulatory pathways. By integrating multi‑omics data and AI‑driven molecule design, the company creates small‑molecule agents aimed at enhancing the body’s natural anti‑cancer response. Its platform focuses on precise activation of innate immunity to improve efficacy and reduce side effects in oncology patients.

Seprify produces high‑performance functionalingredients derived from renewable cellulose for use in coatings, cosmetics, food, inks, pharma, and other industries. Their plant‑based materials are biodegradable, safe, and designed to replace traditional petrochemical additives while reducing carbon emissions. The company offers ready‑to‑use, sustainable solutions that enhance product performance and support circular bioeconomy goals.

Tethys Robotics develops compact underwater drones designed for high-resolution inspections in challenging marine environments, specifically targeting offshore oil and gas, offshore wind, and search and rescue operations. These drones enhance safety for professional divers and minimize environmental impact by enabling efficient and reliable underwater assessments.

WattAnyWhere provides off-grid, renewable energy generation using patented solid oxide fuel cell technology that converts ethanol into clean electricity. This compact, scalable system offers reliable, high-density power deployment for industries like retail and EV charging, independent of grid constraints. The solution delivers pollutant-free power while producing ultra-pure water as a valuable byproduct.